|
PLEKHA7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.840790E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.122540E-03 |
| Normal-vs-Stage2 |
6.495900E-03 |
| Normal-vs-Stage3 |
1.595420E-03 |
| Normal-vs-Stage4 |
8.206700E-04 |
| Stage1-vs-Stage2 |
6.952400E-01 |
| Stage1-vs-Stage3 |
6.738800E-01 |
| Stage1-vs-Stage4 |
3.488800E-01 |
| Stage2-vs-Stage3 |
9.383800E-01 |
| Stage2-vs-Stage4 |
7.329000E-01 |
| Stage3-vs-Stage4 |
6.465800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.295960E-03 |
| Normal-vs-AfricanAmerican |
1.843640E-01 |
| Normal-vs-Asian |
1.219620E-03 |
| Caucasian-vs-AfricanAmerican |
5.276600E-01 |
| Caucasian-vs-Asian |
3.872400E-01 |
| AfricanAmerican-vs-Asian |
1.994250E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.001700E-02 |
| Normal-vs-Female |
8.1115000000076E-05 |
| Male-vs-Female |
3.760800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.168250E-02 |
| Normal-vs-Age(41-60Yrs) |
1.020360E-03 |
| Normal-vs-Age(61-80Yrs) |
6.012900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.399600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.807200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.099000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.769700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.600200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.828400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.585400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.000000E-01 |
| Classical-VS-Follicular |
1.9767599999998E-05 |
| Classical-VS-Other |
6.909200E-01 |
| Classical-VS-Normal |
1.063950E-02 |
| Tall-VS-Follicular |
7.301800E-02 |
| Tall-VS-Other |
8.448400E-01 |
| Tall-VS-Normal |
4.369800E-02 |
| Follicular-VS-Other |
3.262000E-01 |
| Follicular-VS-Normal |
2.23120000253374E-08 |
| Other-VS-Normal |
1.216170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.639800E-04 |
| Normal-vs-N1 |
1.942960E-03 |
| N0-vs-N1 |
7.400600E-01 |
|
|
